In utero hematopoietic stem cell transplantation: progress toward clinical application

Area of Science:

• Reproductive Medicine
• Immunology
• Hematology

Background:

• Congenital hematologic disorders can be treated with hematopoietic stem cell transplantation (HSCT).
• In utero hematopoietic stem cell transplantation (IUHCT) is explored as an alternative to postnatal HSCT.
• IUHCT aims to leverage natural developmental processes for improved engraftment and tolerance.

Purpose of the Study:

• To evaluate the potential of IUHCT as a therapeutic strategy for congenital hematologic disorders.
• To investigate the challenges and progress in achieving therapeutic engraftment via IUHCT.
• To explore the use of IUHCT for inducing donor-specific tolerance to facilitate postnatal HSCT.

Main Methods:

• The study reviews experimental progress and clinical strategies related to IUHCT.
• Focus is placed on the immunological aspects of facilitating allogeneic hematopoietic engraftment in utero.
• The induction of donor-specific tolerance through minimal engraftment is examined.

Main Results:

• Achieving therapeutic levels of engraftment with IUHCT alone remains a significant challenge.
• Considerable experimental progress has been made in developing IUHCT strategies.
• The induction of donor-specific tolerance via IUHCT shows promise for future applications.

Conclusions:

• IUHCT holds potential for treating congenital hematologic disorders diagnosed prenatally.
• A key strategy involves using IUHCT to induce tolerance, enabling safer postnatal HSCT.
• This tolerance-induction approach may lead to broader clinical applications of IUHCT.